share_log

HC Wainwright & Co. Maintains Buy on Cabaletta Bio, Raises Price Target to $25

Benzinga ·  Nov 10, 2023 07:51

HC Wainwright & Co. analyst Douglas Tsao maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target from $17 to $25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment